Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Clinical consequences of ADRbeta2 polymorphisms.

Pharmacogenomics - 1 Mar 2008

Hawkins Gregory A, Weiss Scott T, Bleecker Eugene R

Abstract excerpt

The most prescribed medication for controlling bronchoconstriction associated with asthma and chronic obstructive pulmonary disease are beta-agonists. The gene ADRbeta2 encodes the beta-2-adrenergic receptor and contains several common genetic variations that affect gene expression and receptor function in vitro. The ADRbeta2 variations Gly(16)Arg and Gln(27)Glu and, more recently, haplotypic variations, have...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Adrenergic beta-Agonists
Share to Anti-Asthmatic Agents
Share to Asthma

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Base Sequence

Share to Genetic Variation

Share to Polymorphism, Genetic

Share to Polymorphism, Single Nucleotide

Share to Receptors, Adrenergic, beta-2

Source

Identifiers

PMID: 18303970
DOI: 10.2217/14622416.9.3.349

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Clinical consequences of ADRbeta2 polymorphisms.PMID 18303970Read ↗

Pharmacogenetics of β2-AgonistsSemantic proximity Read ↗

Genetic variation of the beta(2)-adrenoceptor: its functional and clinical importance in bronchial asthma.Semantic proximity Read ↗

The significance of beta2-adrenergic receptor polymorphisms in asthma.Semantic proximity Read ↗

Pharmacogenetics of β2 adrenergic receptor gene polymorphisms, long-acting β-agonists and asthmaSemantic proximity Read ↗

Effect of ADRB2 polymorphisms on response to longacting beta2-agonist therapy: a pharmacogenetic analysis of two randomised studies.Semantic proximity Read ↗

Beta2-adrenoceptor polymorphisms and obstructive airway diseases: important issues of study design.Semantic proximity Read ↗

Pharmacogenomics of long-acting β2-agonists.Semantic proximity Read ↗

Do genetic polymorphisms alter patient response to inhaled bronchodilators?Semantic proximity Read ↗

beta-Adrenergic receptor polymorphisms: relationship to the beta-agonist controversy and clinical implications.Semantic proximity Read ↗

The impact of genomic variants on patient response to inhaled bronchodilators: a comprehensive update.Semantic proximity Read ↗

Pharmacogenetics of the beta 2-adrenergic receptor gene.Semantic proximity Read ↗

Treatment response heterogeneity in asthma: the role of genetic variation.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.